Skip to main content
Top

Drugs

Issue 12/2018

Content (11 Articles)

Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease

  • Open Access
  • Leading Article

Denis Fouque, Marc Vervloet, Markus Ketteler

Adult-Onset Still’s Disease: Molecular Pathophysiology and Therapeutic Advances

  • Leading Article

Paolo Sfriso, Sara Bindoli, Paola Galozzi

Metastatic Melanoma: Recent Therapeutic Progress and Future Perspectives

  • Review Article

Nausicaa Malissen, Jean-Jacques Grob

Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option

  • Review Article

Mellar P. Davis, Gavril Pasternak, Bertrand Behm

Perioperative Use of Intravenous Lidocaine

  • Review Article

Marc Beaussier, Alain Delbos, Axel Maurice-Szamburski, Claude Ecoffey, Luc Mercadal

Alectinib: A Review in Advanced, ALK-Positive NSCLC

  • Adis Drug Evaluation

Julia Paik, Sohita Dhillon

Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections

  • Open Access
  • Adis Drug Evaluation

Sohita Dhillon

Danoprevir: First Global Approval

  • AdisInsight Report

Anthony Markham, Susan J. Keam

Encorafenib and Binimetinib: First Global Approvals

  • AdisInsight Report

Matt Shirley

Correction to: Andexanet Alfa: First Global Approval

  • Open Access
  • Correction

Young-A Heo

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images